Study links prepartum bloodwork to disease risk in dairy cows

A new retrospective study in Animals suggests that routine prepartum bloodwork may help identify dairy cows at higher risk for several important periparturient disorders before clinical signs appear. The paper, Prepartum Blood Biochemistry and Periparturient Disease Risk in Dairy Cows: A Retrospective Two-Farm Study, evaluated 419 calving events from two Korean dairy farms and screened 29 hematology and biochemistry parameters for links to retained placenta, dystocia, abortion or stillbirth, ketosis, and milk fever. (frontiersin.org)

That focus fits a long-running challenge in dairy medicine. The transition period remains one of the highest-risk windows for disease, welfare problems, and economic loss, with prior reviews estimating that 30% to 50% of dairy cows experience some metabolic or infectious disorder around calving. Retained placenta, ketosis, hypocalcemia, uterine disease, and calving-related complications are especially important because they often cluster together and can affect milk yield, fertility, culling risk, and labor demands. (mdpi.com)

The Korean study’s design also reflects a practical field question: whether information already available from prepartum sampling can be used more effectively. According to the study summary, cows were sampled twice before calving on alternating biweekly schedules, then grouped into an early window around 4 to 3 weeks prepartum and a late window around 2 to 1 weeks prepartum. The authors examined associations between those analytes and later disease events rather than focusing on a single disorder alone. That broader approach builds on earlier work from some of the same investigators, including a 2023 study comparing prepartum blood parameters in cows that later developed postpartum ketosis. (frontiersin.org)

While the full article details were not fully surfaced in search results, the abstract indicates that the screened panel included biochemistry and hematology markers relevant to energy balance, liver function, and mineral status. That matters because previous studies have repeatedly tied elevated prepartum NEFA, low calcium, and changes in cholesterol and related metabolites to higher odds of postpartum disease. One recent cohort study suggested that NEFA concentrations 3 to 5 weeks before calving may already help identify cows at risk, while other field studies have linked pre- and postcalving NEFA and calcium thresholds with disorders such as displaced abomasum, ketosis, retained placenta, and other early-lactation disease. (pubmed.ncbi.nlm.nih.gov)

Industry and academic commentary in the broader literature points in the same direction: transition-cow risk is multifactorial, so no single lab value is likely to be enough on its own. Reviews of hypocalcemia, metabolic inflammation, and postpartum uterine disease all emphasize that metabolic markers need to be interpreted alongside parity, body condition, nutrition, immune status, calving management, and herd disease patterns. In other words, the most useful application for veterinarians may be risk stratification, not diagnosis in isolation. That’s an inference from the wider evidence base, but it is consistent with how transition-cow medicine is evolving. (mdpi.com)

Why it matters: For veterinarians working with dairy herds, this study supports a more proactive use of prepartum blood testing. If routine analytes can reliably identify cows trending toward retained placenta, dystocia, ketosis, or milk fever, practices could target fresh-cow exams, ration review, calcium management, body-condition interventions, and postpartum monitoring more precisely. That could be especially useful for herds already collecting close-up cow bloodwork but not yet using it as a structured forecasting tool. (pubmed.ncbi.nlm.nih.gov)

There are also limits that matter clinically. This was a two-farm retrospective study, so external validity is still an open question, and biomarker performance can shift with herd management, diet, parity structure, and disease definitions. Earlier studies have found useful associations, but turning those into decision-ready cutoffs with acceptable sensitivity and specificity has been harder. That means veterinary teams should view the findings as supportive evidence for transition-cow monitoring programs, not as a standalone screening rule ready for universal adoption. (pubmed.ncbi.nlm.nih.gov)

What to watch: The key next step is prospective, multi-herd validation to determine which prepartum markers, or combinations of markers, are robust enough to guide intervention timing, treatment protocols, or herd-level prevention strategies before calving. (pubmed.ncbi.nlm.nih.gov)